Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Aortic valve stenosis Stories

2012-08-29 07:46:34

Transcatheter aortic valve implantation (TAVI) leads to meaningful improvements in health-related quality of life in patients with severe aortic stenosis that are maintained for at least 1 year, according to a study presented at ESC Congress 2012. The results from the German transcatheter aortic valve interventions registry were presented by Professor Till Neumann, MD, from Essen, Germany. Aortic stenosis is the most common valvular heart disease with increasing incidence especially with...

2012-08-29 07:44:03

Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI. The findings were presented at ESC Congress 2012 by Professor Karin Humphries from St. Paul's Hospital. More than 1.5 million people in the US suffer from aortic stenosis, a progressive disease where the aortic valve becomes obstructed, leading to life-threatening...

2012-06-26 02:27:26

Two Local Seniors Share Their Story CINCINNATI, June 26, 2012 /PRNewswire-USNewswire/ -- Nearly one in every eight Americans aged 75 and older will be diagnosed with valvular heart disease. Many of these patients suffer from a severe form of valve disease that requires their diseased aortic valve to be replaced. Transcatheter aortic valve replacement (TAVR) has been studied in clinical trials for patients whose heart valves need replacing, but are at increased risk for open-heart...

2012-05-17 06:25:29

NEWARK, Del., May 17, 2012 /PRNewswire-USNewswire/ -- Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography. (Photo - http://photos.prnewswire.com/prnh/20120517/DC09321) (Logo - http://photos.prnewswire.com/prnh/20090407/DC95299LOGO) The findings - presented May 10 in in Las Vegas during the Society for Cardiovascular Angiography and Interventions' annual...

2012-05-15 06:29:21

NATICK, Mass., May 15, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus(TM) Aortic Valve System in patients with severe aortic valve disease. The Lotus Aortic Valve System is the first transcatheter aortic valve replacement (TAVR) device of its kind that is designed to minimize aortic regurgitation (leaking) and is both fully repositionable and retrievable prior to release....

2012-04-23 02:28:26

NATICK, Mass., April 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus(TM) Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release. This prospective, single-arm feasibility study enrolled...

2012-04-10 13:49:15

TAVI improves heart function and exercise capacity German researchers report success with transcatheter aortic valve implantation (TAVI) in patients with low-flow, low-gradient aortic stenosis–a special form of aortic stenosis that is difficult to treat. Results published in the April issue of Catheterization and Cardiovascular Interventions, the peer-reviewed journal of the Society for Cardiovascular Angiography and Interventions (SCAI), show that while all-cause mortality was high...

2012-04-10 12:24:34

TAVI Improves Heart Function and Exercise Capacity German researchers report success with transcatheter aortic valve implantation (TAVI) in patients with low-flow, low-gradient aortic stenosis–a special form of aortic stenosis that is difficult to treat. Results published in the April issue of Catheterization and Cardiovascular Interventions, the peer-reviewed journal of the Society for Cardiovascular Angiography and Interventions (SCAI), show that while all-cause mortality was high...

2012-03-26 23:45:08

Study finds novel procedure comparable to open-heart surgery for high-risk seniors Two-year data show comparable death and durability for catheter-placed heart valves and open-heart surgery in very old and ill patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field. An estimated 5...